ArticleJournal of cancer research and clinical oncology2024

Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma.

Bao-Ye Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.